Latest Intelligence on Sales and Marketing

Published within

« | ... | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Sanofi: growth leader, but doubts remain

Sanofi-Synthelabo's recent growth record is impressive. However, important questions remain: what will happen to Sanofi's intellectual property rights on Plavix, and how successful will its pipeline products be? Although Sanofi's chances of losing the Plavix case look low, its current dependence on the drug makes any risk of defeat slightly troubling.

Published By Datamonitor
23 Oct 2002
CommentWire
CommentWire

AOL: banners and pop-ups sent to pasture

AOL's decision to axe pop-up adverts highlights the problems in the online advertising market: the irritation that pop-ups cause to customers can often be greater than the revenues they bring in. The trick going forward is to capture the attention of the consumers without irritating them; if companies can manage this, the online advertising market should pick up.

Published By Datamonitor
18 Oct 2002
CommentWire
CommentWire

Constellation: building Brit base with branded bottles

Matthew Clark's new wine highlights the importance of creating a distinctive brand to compete in the expanding wine market. Echo Falls' branding aims at authenticity, pedigree and class, belying its sub-GBP4 price point. Successful branding simplifies the choice facing consumers in the off-license and increases the chance of repeat custom.

Published By Datamonitor
11 Oct 2002
CommentWire
CommentWire

GlaxoSmithKline: addicted to advertising Paxil

Even though GSK denies allegations that its antidepressant Paxil is addictive, its new ad campaign no longer describes the drug as 'non-habit forming'. The move follows a US court ruling (against the FDA's advice) that the claim was not justified. GSK is trying to get that decision reversed, but pulling Paxil ads in the meantime would be a quixotic gesture.

Published By Datamonitor
27 Sep 2002
CommentWire
CommentWire

Safeway: 'disloyalty' scheme could be a winner

Loyalty card schemes are beginning to fall out of favor with retailers. Sainsbury's has drastically altered its offering; now, Safeway is gambling that short-term offers will seduce customers away from their current supermarket. Both strategies are based on the realization that customers do not choose supermarkets in the hope of long-term reward.

Published By Datamonitor
23 Sep 2002
CommentWire
CommentWire

General Motors: fueling the discount war

Just two weeks after pulling the plug on its 0% financing scheme, General Motors is reintroducing them - after sales fell without the incentive. But US sales can't be sustained forever at the artificial levels seen over the last 12 months. The 'big three' will eventually have to accept falling sales.

Published By Datamonitor
23 Sep 2002
CommentWire
CommentWire

Green & Black: it's all me, me, me

Green & Black's organic chocolate is being repackaged and relaunched for the mass market. Despite success the niche organic market, it has until now failed to get into most consumers' shopping baskets. By emphasizing the quality and luxury aspects of the chocolate, and placing the organic/ethical benefits in the shade, the brand will have a better chance of widening its appeal.

Published By Datamonitor
19 Sep 2002
CommentWire
CommentWire

AstraZeneca: Atacand gets a better label

Atacand is now the only ARB to boast superiority in its labeling, in terms of blood pressure lowering, over the market leader and first entrant, Merck's Cozaar. However, the unique claim could be short-lived. Other newer agents in the class, also with proven superiority over losartan, are applying for similar labeling changes.

Published By Datamonitor
19 Sep 2002
CommentWire
CommentWire

Laurel: aiming for bullseye

Pub operator Laurel is taking part in a darts sponsorship deal in the UK. Laurel will hold qualifying rounds in its own pubs, which will see amateurs battling it out for the right to take on the professionals in the final stages. The campaign highlights that the fact that increasing consumer participation in promotions is the way ahead.

Published By Datamonitor
16 Sep 2002
Expert View
Expert View

ePharma: targeting the online health conscious

Unlike Internet penetration as a whole, the market for online health information is far from saturated. The audience for health information online is substantial and growing organically. So how can pharmaceutical companies capitalize on this eager audience?

Published By Datamonitor
13 Sep 2002

« | ... | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ... | » »|

No help is available.